- Home
- ALLK vs CLEU Comparison
ALLK vs CLEU Comparison
Compare ALLK & CLEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLK
- CLEU
- Stock Information
- Founded
- ALLK 2012
- CLEU 2011
- Country
- ALLK United States
- CLEU China
- Employees
- ALLK N/A
- CLEU N/A
- Industry
- ALLK Biotechnology: Pharmaceutical Preparations
- CLEU Other Consumer Services
- Sector
- ALLK Health Care
- CLEU Real Estate
- Exchange
- ALLK Nasdaq
- CLEU Nasdaq
- Market Cap
- ALLK 23.0M
- CLEU 20.0M
- IPO Year
- ALLK 2018
- CLEU 2020
- Fundamental
- Price
- ALLK $0.32
- CLEU $1.93
- Analyst Decision
- ALLK Hold
- CLEU
- Analyst Count
- ALLK 3
- CLEU 0
- Target Price
- ALLK $2.00
- CLEU N/A
- AVG Volume (30 Days)
- ALLK 1.8M
- CLEU 174.8K
- Earning Date
- ALLK 03-12-2025
- CLEU 10-11-2024
- Dividend Yield
- ALLK N/A
- CLEU N/A
- EPS Growth
- ALLK N/A
- CLEU N/A
- EPS
- ALLK N/A
- CLEU N/A
- Revenue
- ALLK N/A
- CLEU $2,413,409.00
- Revenue This Year
- ALLK N/A
- CLEU N/A
- Revenue Next Year
- ALLK N/A
- CLEU N/A
- P/E Ratio
- ALLK N/A
- CLEU N/A
- Revenue Growth
- ALLK N/A
- CLEU N/A
- 52 Week Low
- ALLK $0.22
- CLEU $0.05
- 52 Week High
- ALLK $1.56
- CLEU $7.90
- Technical
- Relative Strength Index (RSI)
- ALLK 59.90
- CLEU 50.10
- Support Level
- ALLK $0.24
- CLEU $1.80
- Resistance Level
- ALLK $0.27
- CLEU $2.24
- Average True Range (ATR)
- ALLK 0.01
- CLEU 0.30
- MACD
- ALLK 0.01
- CLEU -0.02
- Stochastic Oscillator
- ALLK 96.94
- CLEU 14.61
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.
About CLEU China Liberal Education Holdings Limited
China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.